Single-Cell Sequencing for Drug Discovery and Drug Development

Area of Science:

• Genomics
• Biomedical Research
• Drug Discovery

Background:

• Next-generation sequencing (NGS) and single-cell sequencing have transformed genomic and biomedical research.
• Technological advancements now enable deep whole-genome (DNA-seq), whole epigenome, and whole-transcriptome (RNA-seq) sequencing at the single-cell level.
• Single-cell sequencing offers unprecedented throughput and single-nucleotide resolution for exploring biological systems without prior assumptions.

Purpose of the Study:

• To review the current state of single-cell sequencing techniques.
• To highlight the utility of single-cell sequencing for drug discovery and development.
• To discuss the advantages and challenges of various single-cell sequencing approaches.

Main Methods:

• Single-cell whole genome/exome sequencing (scWGS/scWES)
• Single-cell transcriptome sequencing (scRNA-seq)
• Single-cell bisulfite sequencing (scBS)
• Multi-omics single-cell sequencing

Main Results:

• Single-cell sequencing provides a precise approach for analyzing drug effects on cells and tissues.
• Various single-cell sequencing methods offer distinct advantages for different research questions.
• The review details the capabilities and limitations of current single-cell sequencing technologies.

Conclusions:

• Single-cell sequencing represents a powerful and precise methodology for advancing drug discovery and development.
• These techniques expand the scope of genomic and epigenomic analysis at an unprecedented resolution.
• Future applications of single-cell sequencing in pharmacology are promising and warrant further exploration.